adairАллергология и Иммунология в ПедиатрииAllergology and Immunology in Paediatrics2500-11752712-7958Ассоциация детских аллергологов и иммунологов России10.53529/2500-1175-2023-4-5-30adair-117Research ArticleОБЗОРREVIEWАллерген-специфическая иммунотерапия у детей. Согласительный документ Ассоциации детских аллергологов и иммунологов России (позиционная статья)Allergen-specific immunotherapy in children. Consensus document of the Association of Pediatric Allergologists and Immunologists of Russia (positional pаper)https://orcid.org/0000-0001-7876-6258СмолкинЮ. С.SmolkinYu. S.

Смолкин Юрий Соломонович - д. м. н., профессор кафедры клинической иммунологии и аллергологии Академии постдипломного образования

125371, г. Москва, Волоколамское ш., д. 91

Yuri Solomonovich Smolkin - Doc. Sci., Professor of Department of Clinical Immunology and Allergology of Academy of Postgraduate Education under

91 Volokolamskoe highway, 125371, Moscow

smolkin@alerg.ruhttps://orcid.org/0000-0002-0854-1536ТрусоваО. В.TrusovaO. V.

Трусова Ольга Валерьевна - к. м. н., доцент кафедры терапии госпитальной с курсом аллергологии и иммунологии им. ак. М. В. Черно руцкого с клиникой

197022, г. Санкт-Петербург, ул. Льва Толстого, д. 6–8

Olga Valerievna Trusova - Cand. Sci., Associate Professor Department of Hospital Therapy with the Course of Allergology and Immunology named after Academician M. V. Chernorutsky with the clinic

6–8 L’va Tolstogo st., St. Petersburg, 197022

o-tru@mail.ruhttps://orcid.org/0009-0005-3836-0428АлискандиеваЗ. А.AliskandievaZ. A.

Алискандиева Зулейха Алаутдиновна - к. м. н., доцент кафедры факультетской и госпитальной педиатрии

367012, г. Махачкала, пл. им. Ленина, д. 1

Zuleikha Alautdinovna Aliskandieva - Cand. Sci., Associate Professor Department of Faculty and Hospital Pediatrics

1 Lenina Sq., Makhachkala, 367012

aliskandieva@mail.ruhttps://orcid.org/0000-0002-4069-0566БарычеваЛ. Ю.BarychevaL. Y.

Барычева Людмила Юрьевна - д. м. н., профессор, заведующая кафедрой иммунологии с курсом ДПО

355017, г. Ставрополь, ул. Мира, д. 310

Liudmila Yur’evna Barycheva - Dr. Sci., Рrofessor, Head of the Department of Immunology with a course of continuing professional education

310 Mira st., Stavropol, 355017

for_ludmila@inbox.ruhttps://orcid.org/0000-0002-4636-1819БогомазовА. Д.BogomazovA. D.

Богомазов Алексей Дмитриевич - к. м. н., доцент кафедры педиатрии

305041, г. Курск, ул. Карла Маркса, д. 3

Alexey Dmitrievich Bogomazov - Cand. Sci., Associate Professor Department of Pediatrics

3 Karla Marksa st., Kursk, 305041

bogomazov71@mail.ruhttps://orcid.org/0000-0001-5540-924XБочароваК. А.BocharovaK. A.

Бочарова Ксения Александровна - к. м. н., доцент, доцент кафедры семейной медицины медицинского института

308015, г. Белгород, ул. Победы, д. 85

Ksenia Aleksandrovna Bocharova - Cand. Sci., Associate Professor, Associate Professor of Department of Family Medicine of the Medical Institute

85 Pobedy st., Belgorod, 308015

doctor.bocharova@mail.ruЕмелинаЮ. Н.EmelinaYu. N.

Емелина Юлия Николаевна - к. м. н., врач аллерголог-иммунолог

620134, г. Екатеринбург, ул. Решетская, д. 51

Yuliya Nikolaevna Emelina - Cand. Sci., allergist-immunologist

51 Reshetskaya st., Sverdlovsk Region, Sverdlovsk Region Center, Yekaterinburg, 620134

eyun75@mail.ruhttps://orcid.org/0000-0001-9654-3429КамаевА. В.KamaevA. V.

Камаев Андрей Вячеславович - к. м. н., доцент, доцент кафедры общей врачебной практики (семейной медицины)

197022, г. Санкт-Петербург, ул. Льва Толстого, д. 6–8

Andrey Vyacheslavovich Kamaev - Cand. Sci., Associate Professor, Associate Professor Department of General Medical Practice

6–8 L’va Tolstogo st., St. Petersburg, 197022

andykkam@mail.ruhttps://orcid.org/0000-0001-7640-0754ЛарьковаИ. А.LarkovaI. A.

Ларькова Инна Анатольевна - к. м. н., старший научный сотрудник отделения аллерго

109240, г. Москва, Устьинский пр., д. 2/14

Inna Anatolevna Larkova - Cand. Sci., Senior researcher of Allergy Department

2/14 Ustinskiy proezd, Moscow, 109240

inna_larkova@mail.ruhttps://orcid.org/0009-0000-4513-2208МархайчукА. З.MarkhaichukA. Z.

Мархайчук Айшат Зиябутдиновна - врач аллерголог-иммунолог Консультативно-диагностического центра для детей

236017, г. Калининград, ул. Д. Донского, д. 23

Aishat Ziyabutdinovna Markhaichuk - allergologist-immunologist, Consultative and Diagnostic Center for Children

Kaliningrad, 23 D. Donskogo st., 236017

ayshat.90@rambler.ruhttps://orcid.org/0000-0002-2048-5709МасальскийС. С.MasalskiyS. S.

Масальский Сергей Сергеевич - к. м. н., доцент кафедры акушерства, гинекологии и педиатрии

125466, г. Москва, ул. Соколово-Мещерская, д. 29

Sergey Sergeevich Masalskiy - Cand. Sci., Associate Professor of the Department of Obstetrics, Gynecology and Pediatrics

29 Sokolovo-Meshcherskaya st., 125466, Moscow

masalsky@live.comhttps://orcid.org/0000-0003-0941-9871МигачеваН. Б.MigachevaN. B.

Мигачева Наталья Бегиевна - д. м. н., доцент, заведующая кафедрой педиатрии ИПО

443056, г. Самара, ул. Самарская, д. 137

Natalia Begievna Migacheva - Dr. Sci., Associate Professor, Head of Department of Pediatrics

137 Samarskaya st., Samara, 443056

nbmigacheva@gmail.comhttps://orcid.org/0000-0003-1409-504XПрилуцкийА. С.PrilutskiyA. S.

Прилуцкий Александр Сергеевич - д. м. н., профессор кафедры микробиологии, вирусологии, иммунологии и аллергологии

283003, г. Донецк, пр-т Ильича, д. 16

Aleksandr Sergeevich Prilutskiy - Dr. Sci., Professor of Department of Microbiology, Virology, Immunology and Allergology

16 Ilyicha av., Donetsk, 283003

aspr@mail.ruhttps://orcid.org/0000-0002-1806-0787СтежкинаЕ. В.StezhkinaE. V.

Стежкина Елена Викторовна - к. м. н., доцент кафедры факультетской и поликлинической педиатрии с курсом педиатрии

390026, г. Рязань, ул. Высоковольтная, д. 9

Elena Viktorovna Stezhkina - Cand. Sci., Associate Professor of the Department of Faculty and Polyclinic Pediatrics with the Course of Pediatrics FDPO

Vysokovoltnaya st., Ryazan, 390026

polus1972@yandex.ruhttps://orcid.org/0000-0002-9001-1437ФайзуллинаР. М.FayzullinaR. M.

Файзуллина Резеда Мансафовна - д. м. н., профессор кафедры факультетской педиатрии с курсами педиатрии, неонатологии и симуляционным центром ИДПО

450008, г. Уфа, ул. Ленина, д. 3

Rezeda Mansafovna Fayzullina - Dr. Sci., Professor of the Department of Faculty Pediatrics with Courses in Pediatrics, Neonatology and Simulation Center IDPO

3 Lenina st., Ufa, 450008

fayzullina@yandex.ruhttps://orcid.org/0000-0003-0754-9605ХакимоваР. Ф.KhakimovaR. F.

Хакимова Резеда Фидаиловна - д. м. н., профессор кафедры клинической иммунологии с аллергологией

420012, г. Казань, ул. Бутлерова, д. 49

Rezeda Fidailovna Khakimova - Dr. Sci., Professor of the Department of Clinical Immunology and Allergology

49 Butlerov st., Kazan, 420012

khakimova@yandex.ruhttps://orcid.org/0000-0001-6407-6117ЧурюкинаЭ. В.ChuryukinaE. V.

Чурюкина Элла Витальевна - к. м. н., доцент кафедры клинической иммунологии, аллергологии и лабораторной диагностики ФПК и ППС

344091, г. Ростов-на-Дону, пер. Нахичеванский, д. 29

Ella Vitalievna Churyukina - Cand. Sci., Associate Professor of the Department of Clinical Immunology, Allergology and laboratory diagnostics

29 Nakhichevanskiy lane, Rostov-on-Don, 344091

echuryukina@mail.ruhttps://orcid.org/0000-0002-7143-8259ШаховаН. В.ShakhovaN. V.

Шахова Наталья Викторовна - д. м. н., доцент, заведующий кафедрой госпитальной педиатрии с курсом ДПО

656038, г. Барнаул, пр-т Ленина, д. 40

Natal’ya Victorovna Shakhova - Dr. Sci., Associate Professor, Head of the Department of Hospital Pediatrics with a Course of Additional Professional Education

40 Lenin av., Barnaul, 656038

natalia.shakhova@mail.ruhttps://orcid.org/0000-0001-9826-9654ШиловаТ. В.ShilovaT. V.

Шилова Татьяна Васильевна - к. м. н., доцент кафедры госпитальной педиатрии, клинической иммунологии и аллергологии

454092, г. Челябинск, ул. Воровского, д. 64

Tatiyana Vasilevna Shilova - Associate Professor Department of Hospital Pediatrics, Clinical Immunology and Allergology

64 Vorovsky st., Chelyabinsk, 454092

tanya920477@mail.ruАкадемия постдипломного образования ФГБУ ФНКЦ ФМБА РоссииРоссияAcademy of Postgraduate Education under FSBI FSCC of FMBA of RussiaRussian FederationФГБОУ ВО ПСПбГМУ им. И. П. Павлова Минздрава РоссииРоссияFSBEI HE I. P. Pavlov SPbSMU MOH RussiaRussian FederationФГБОУ ВО ДГМУ Минздрава РоссииРоссияFSBEI HE DSMU MOH RussiaRussian FederationФГБОУ ВО СтГМУ Минздрава РоссииРоссияFSBEI HE StSMU MOH RussiaRussian FederationФГБОУ ВО КГМУ Минздрава РоссииРоссияFSBEI HE KSMU MOH RussiaRussian FederationФГАОУ ВО «Белгородский государственный национальный исследовательский университет»РоссияBelgorod State National Research UniversityRussian FederationГАУЗ ДГКБ № 9РоссияSAHI “Children’s State Clinical Hospital No. 9”Russian FederationФГБУН «ФИЦ питания и биотехнологии»РоссияFederal Research Center of Nutrition and ВiotechnologyRussian FederationГБУЗ «Детская областная больница Калининградской области»РоссияGBUZ “Children’s Regional Hospital of the Kaliningrad Region”Russian FederationМосковский медицинский университет «Реавиз»РоссияMoscow Medical University “Reaviz”Russian FederationФГБОУ ВО СамГМУ Минздрава РоссииРоссияSamara State Medical UniversityRussian FederationФГБОУ ВО ДонГМУ Минздрава РоссииРоссияFSBEI HE DonSMU of MOH of RussiaRussian FederationФГБОУ ВО РязГМУ Минздрава РоссииРоссияFSBEI HE RyazSMU MOH RussiaRussian FederationФГБОУ ВО БГМУ Минздрава РоссииРоссияFSBEI HE BSMU MOH RussiaRussian FederationФГБОУ ВО «Казанский государственный медицинский университет» Минздрава РоссииРоссияFSBEI HE Kazan SMU MOH RussiaRussian FederationФГБОУ ВО РостГМУ Минздрава РоссииРоссияFSBEI HE RostSMU MOH RussiaRussian FederationФГБОУ ВО АГМУ МинздраваРоссияFSBEI HE ASMU MOH RussiaRussian FederationФГБОУ ВО ЮУГМУ Минздрава РоссииРоссияFSBEI HE SUSMU MOH RussiaRussian Federation20230701202404530Copyright © Смолкин Ю.С., Трусова О.В., Алискандиева З.А., Барычева Л.Ю., Богомазов А.Д., Бочарова К.А., Емелина Ю.Н., Камаев А.В., Ларькова И.А., Мархайчук А.З., Масальский С.С., Мигачева Н.Б., Прилуцкий А.С., Стежкина Е.В., Файзуллина Р.М., Хакимова Р.Ф., Чурюкина Э.В., Шахова Н.В., Шилова Т.В., 20242024Смолкин Ю.С., Трусова О.В., Алискандиева З.А., Барычева Л.Ю., Богомазов А.Д., Бочарова К.А., Емелина Ю.Н., Камаев А.В., Ларькова И.А., Мархайчук А.З., Масальский С.С., Мигачева Н.Б., Прилуцкий А.С., Стежкина Е.В., Файзуллина Р.М., Хакимова Р.Ф., Чурюкина Э.В., Шахова Н.В., Шилова Т.В.Smolkin Y.S., Trusova O.V., Aliskandieva Z.A., Barycheva L.Y., Bogomazov A.D., Bocharova K.A., Emelina Y.N., Kamaev A.V., Larkova I.A., Markhaichuk A.Z., Masalskiy S.S., Migacheva N.B., Prilutskiy A.S., Stezhkina E.V., Fayzullina R.M., Khakimova R.F., Churyukina E.V., Shakhova N.V., Shilova T.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://adair.elpub.ru/jour/article/view/117

В Документе содержатся принципиальные положения, касающиеся проведения аллерген-специфической иммунотерапии у детей. Использованы международные клинические рекомендации по методике, адаптированные для применения в условиях реальной практики. В случае отсутствия международных рекомендаций авторами представлено консенсусное мнение участников проекта, основанное на данных клинических исследований. В настоящий момент мы предлагаем вашему вниманию позиционный документ по вопросам аллерген-специфической иммунотерапии у детей, созданный экспертами Ассоциации детских аллергологов и иммунологов России (АДАИР) на основе согласительного документа 2021 г., с необходимыми обновлениями данных.

The Document contains fundamental provisions regarding allergen specific immunotherapy in children.International clinical recommendations on the methodology were used, adapted for use in real practice.In the absence of international recommendations, the authors present the consensus opinion of the project participants, based on data from clinical studies in this area.At the moment, we bring to your attention a position paper on allergen specific immunotherapy in children, created by experts from the Association of Pediatric Allergologists and Immunologists of Russia (APAIR) based on the 2021 consensus document, with the necessary data updates.

аллерген-специфическая иммунотерапиядетисогласительный документallergen-specific immunotherapychildrenconsensus documentReferencesNoon L. Prophylactic inoculations against hay fever. Lancet. 1911; 1: 1572–1573.Noon L. Prophylactic inoculations against hay fever. Lancet. 1911; 1: 1572–1573.Cooke RA. The treatment of hay fever by active immunization. Laryngoscope. 1914; 25: 108–112.Cooke RA. The treatment of hay fever by active immunization. Laryngoscope. 1914; 25: 108–112.Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet. 1911; 178: 814–817.Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet. 1911; 178: 814–817.Meyer-Pittroff R, Behrendt H, Ring J. Specific immuno-modulation and therapy by means of high pressure treated allergens. High Pressure Research. 2007; 27 (1): 63–67.Meyer-Pittroff R, Behrendt H, Ring J. Specific immuno-modulation and therapy by means of high pressure treated allergens. High Pressure Research. 2007; 27 (1): 63–67.Воробьева ОВ, Гущин ИС. Исторические предпосылки создания метода аллерген-специфической иммунотерапии (К 100-летию открытия). Российский аллергологический журнал. 2010; 5: 17–28. [Vorobjova OV, Gushchin IS. Istoricheskie predposylki sozdaniya metoda allergen-specificheskoj immunoterapii (K 100-letiyu otkrytiya). Rossijskij allergologicheskij zhurnal. 2010; 5: 17–28. (In Russ.)Воробьева ОВ, Гущин ИС. Исторические предпосылки создания метода аллерген-специфической иммунотерапии (К 100-летию открытия). Российский аллергологический журнал. 2010; 5: 17–28. [Vorobjova OV, Gushchin IS. Istoricheskie predposylki sozdaniya metoda allergen-specificheskoj immunoterapii (K 100-letiyu otkrytiya). Rossijskij allergologicheskij zhurnal. 2010; 5: 17–28. (In Russ.)Гущин ИС, Курбачева ОМ. Аллергия и аллерген-специфическая иммунотерапия. М.: Фармарус Принт Медиа. 2010; 228: 16.Gushchin IS, Kurbacheva OM. Allergiya i allergen-specificheskaya immunoterapiya. M.: Farmarus Print Media. 2010; 228: 16. (In Russ.)Sahiner UM, Giovannini M, Escribese MM et al. Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. J Pers Med. 2023; 13 (5): 845. https://doi.org/10.3390/jpm13050845.Sahiner UM, Giovannini M, Escribese MM et al. Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. J Pers Med. 2023; 13 (5): 845. https://doi.org/10.3390/jpm13050845.Mitsias D, Xepapadaki P, Makris M, Papadopoulos N. Immunotherapy in allergic diseases — improved understanding and innovation for enhanced effectiveness. Curr Opin Immunol. 2020; 66: 1–8. https://doi.org/10.1016/j.coi.2020.02.005.Mitsias D, Xepapadaki P, Makris M, Papadopoulos N. Immunotherapy in allergic diseases — improved understanding and innovation for enhanced effectiveness. Curr Opin Immunol. 2020; 66: 1–8. https://doi.org/10.1016/j.coi.2020.02.005.Вишнева ЕА, Намазова-Баранова ЛС, Алексеева АА и др. Аллерген-специфическая иммунотерапия у детей: современное состояние вопроса. Педиатрическая фармакология. 2016; 13 (4): 404–408.Vishneva EA, Namazova-Baranova LS, Alekseeva AA et al. Allergen-spetsificheskaya immunoterapiya u detei: sovremennoe sostoyanie voprosa. Pediatricheskaya farmakologiya. 2016; 13 (4): 404–408. (In Russ.)Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J. Allergy Clin. Immunol. 2017; 140 (6): 1485–1498. https://doi.org/10.1016/j.jaci.2017.10.010.Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J. Allergy Clin. Immunol. 2017; 140 (6): 1485–1498. https://doi.org/10.1016/j.jaci.2017.10.010.Alvaro-Lozano M, Akdis CA, Akdis M et al. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol. 2020; 25 (25): 1–101. https://doi.org/10.1111/pai.13189.Alvaro-Lozano M, Akdis CA, Akdis M et al. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol. 2020; 25 (25): 1–101. https://doi.org/10.1111/pai.13189.Pavón-Romero GF, Parra-Vargas MI, Ramírez-Jiménez F et al. Allergen Immunotherapy: Current and Future Trends. Cells. 2022; 11 (2): 212. https://doi.org/10.3390/cells11020212.Pavón-Romero GF, Parra-Vargas MI, Ramírez-Jiménez F et al. Allergen Immunotherapy: Current and Future Trends. Cells. 2022; 11 (2): 212. https://doi.org/10.3390/cells11020212.Yu JC, Khodadadi H, Malik A et al. Innate Immunity of Neonates and Infants. Front Immunol. 2018; 9: 1759. https://doi.org/10.3389/fimmu.2018.01759.Yu JC, Khodadadi H, Malik A et al. Innate Immunity of Neonates and Infants. Front Immunol. 2018; 9: 1759. https://doi.org/10.3389/ fimmu.2018.01759.Belderbos M, Levy O, Bont L. Neonatal innate immunity in allergy development. Curr Opin Pediatr. 2009; 21 (6): 762–769. https://doi.org/10.1097/MOP.0b013e3283325e3a.Belderbos M, Levy O, Bont L. Neonatal innate immunity in allergy development. Curr Opin Pediatr. 2009; 21 (6): 762–769. https://doi.org/10.1097/MOP.0b013e3283325e3a.Zielen S, Devillier P, Heinrich J et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis. Allergy. 2018; 73 (1): 165–177. https://doi.org/10.1111/all.13213.Zielen S, Devillier P, Heinrich J et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis. Allergy. 2018; 73 (1): 165–177. https://doi.org/10.1111/all.13213.Матвеева ЛП, Ермакова ЛА. Экспертиза лечения поллиноза у детей аллергоидами и аллергенами. Проблемы экспертизы в медицине. 2006; 3: 42–44.Matveeva LP, Ermakova LA. Ekspertiza lecheniya pollinoza u detej allergoidami i allergenami. Problemy ekspertizy v medicine. 2006; 3: 42–44. (In Russ.)Barnes C, Portnoy JM, Ciaccio CE, Pacheco F. A comparison of subject room dust with home vacuum dust for evaluation of dustborne aeroallergens. Ann Allergy Asthma Immunol. 2013; 110 (5): 375–379. https://doi.org/10.1016/j.anai.2013.02.010.Barnes C, Portnoy JM, Ciaccio CE, Pacheco F. A comparison of subject room dust with home vacuum dust for evaluation of dustborne aeroallergens. Ann Allergy Asthma Immunol. 2013; 110 (5): 375–379. https://doi.org/10.1016/j.anai.2013.02.010.Mattsson L, Lundgren T, Everberg H et al. Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol. 2009; 123 (2): 362–368. https://doi.org/10.1016/j.jaci.2008.11.021.Mattsson L, Lundgren T, Everberg H et al. Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol. 2009; 123 (2): 362–368. https://doi.org/10.1016/j.jaci.2008.11.021.Van Ree R, Chapman MD, Ferreira F, et al. The CREATE Project: Development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy: European Journal of Allergy and Clinical Immunology. 2008; 63 (3): 310–326. https://doi.org/10.1111/j.1398-9995.2007.01612.x.Van Ree R, Chapman MD, Ferreira F, et al. The CREATE Project: Development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy: European Journal of Allergy and Clinical Immunology. 2008; 63 (3): 310–326. https://doi.org/10.1111/j.1398-9995.2007.01612.x.Larenas-Linnemann D, Cox LS. Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol. 2008; 100 (2): 137–145. https://doi.org/10.1016/S1081-1206(10)60422-X.Larenas-Linnemann D, Cox LS. Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol. 2008; 100 (2): 137–145. https://doi.org/10.1016/S1081-1206(10)60422-X.Государственная фармакопея. XIII изд. ОФС.1.7.1.0001.15. Аллергены. Веб-ресурс: https://pharmacopoeia.ru/ofs-1-7-1-0001-15-allergeny/#%D0%98%D0%A1%D0%9F%D0%AB%D0%A2%D0%90%D0%9D%D0%98%D0%AF. Время доступа 08.06.2023.Gosudarstvennaya farmakopeya. XIII izd. OFS.1.7.1.0001.15. Allergeny. Veb-resurs: https://pharmacopoeia.ru/ofs-1-7-1-0001-15-allergeny/#%D0%98%D0%A1%D0%9F%D0%AB%D0%A2%D0%90%D0%9D%D0%98%D0%AF. Vremya dostupa 08.06.2023. (In Russ.)Lund K, Kito H, Skydtsgaard MB et al. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations. Clin Ther. 2019; 41 (4): 742–753. https://doi.org/10.1016/j.clinthera.2019.02.008.Lund K, Kito H, Skydtsgaard MB et al. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations. Clin Ther. 2019; 41 (4): 742–753. https://doi.org/10.1016/j.clinthera.2019.02.008.Wahn U, Bachert C, Heinrich J et al. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy. 2019; 74 (3): 594–604. https://doi.org/10.1111/all.13598.Wahn U, Bachert C, Heinrich J et al. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy. 2019; 74 (3): 594–604. https://doi.org/10.1111/all.13598.Gangl K, Niederberger V, Valenta R. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. 2013; 43 (11): 1202–1216. https://doi.org/10.1111/cea.12128.Gangl K, Niederberger V, Valenta R. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. 2013; 43 (11): 1202–1216. https://doi.org/10.1111/cea.12128.Gunawardana NC, Durham SR. New approaches to allergen immunotherapy. Ann Allergy Asthma Immunol. 2018; 121 (3): 293–305. https://doi.org/10.1016/j.anai.2018.07.014.Gunawardana NC, Durham SR. New approaches to allergen immunotherapy. Ann Allergy Asthma Immunol. 2018; 121 (3): 293–305. https://doi.org/10.1016/j.anai.2018.07.014.Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy. 2011; 66 (6): 713–724. https://doi.org/10.1111/j.1398-9995.2010.02541.x.Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy. 2011; 66 (6): 713–724. https://doi.org/10.1111/j.1398-9995.2010.02541.x.Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol. 2007; 119: 826–830.Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol. 2007; 119: 826–830.Riabova K, Karsonova AV, van Hage M, et al. Molecular Allergen-Specific IgE Recognition Profiles and Cumulative Specific IgE Levels Associated with Phenotypes of Cat Allergy. Int J Mol Sci. 2022; 23 (13): 6984. Published 2022 Jun 23. https://doi.org/10.3390/ijms23136984.Riabova K, Karsonova AV, van Hage M, et al. Molecular Allergen-Specific IgE Recognition Profiles and Cumulative Specific IgE Levels Associated with Phenotypes of Cat Allergy. Int J Mol Sci. 2022; 23 (13): 6984. Published 2022 Jun 23. https://doi.org/10.3390/ijms23136984.Ding B, Lai Y, Lu Y. Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis. Allergol Immunopathol (Madr). 2023; 51 (2): 184–190. Published 2023 Mar 1. https://doi.org/10.15586/aei.v51i2.778.Ding B, Lai Y, Lu Y. Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis. Allergol Immunopathol (Madr). 2023; 51 (2): 184–190. Published 2023 Mar 1. https://doi.org/10.15586/aei.v51i2.778.Casale TB, Busse WW, Kline JN et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2006; 117: 134–140.Casale TB, Busse WW, Kline JN et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2006; 117: 134–140.Rodríguez Del Río P, Vidal C, Just J, et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment. Pediatr Allergy Immunol. 2017; 28 (1): 60–70. https://doi.org/10.1111/pai.12660.Rodríguez Del Río P, Vidal C, Just J, et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment. Pediatr Allergy Immunol. 2017; 28 (1): 60–70. https://doi.org/10.1111/pai.12660.Calderón MA, Vidal C, Rodríguez Del Río P, et al. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment. Allergy. 2017; 72 (3): 462–472. https://doi.org/10.1111/all.13066.Calderón MA, Vidal C, Rodríguez Del Río P, et al. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment. Allergy. 2017; 72 (3): 462–472. https://doi.org/10.1111/all.13066.Calderón MA, Simons FE, Malling HJ, et al. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy. 2012; 67 (3): 302–311. https://doi.org/10.1111/j.1398-9995.2011.02761.x.Calderón MA, Simons FE, Malling HJ, et al. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy. 2012; 67 (3): 302–311. https://doi.org/10.1111/j.1398-9995.2011.02761.x.Di Bona D, Magistà S, Masciopinto L, et al. Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study. Respir Med. 2020; 161: 105843. https://doi.org/10.1016/j.rmed.2019.105843.Di Bona D, Magistà S, Masciopinto L, et al. Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study. Respir Med. 2020; 161: 105843. https://doi.org/10.1016/j.rmed.2019.105843.Pfaar O, Bachert C, Bufe A, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int. 2014; 23 (8): 282–319. https://doi.org/10.1007/s40629-014-0032-2.Pfaar O, Bachert C, Bufe A, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int. 2014; 23 (8): 282–319. https://doi.org/10.1007/s40629-014-0032-2.Sánchez-Borges M, Bernstein DI, Calabria C. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors. Immunol Allergy Clin North Am. 2020; 40 (1): 25–39. https://doi.org/10.1016/j.iac.2019.09.001.Sánchez-Borges M, Bernstein DI, Calabria C. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors. Immunol Allergy Clin North Am. 2020; 40 (1): 25–39. https://doi.org/10.1016/j.iac.2019.09.001.Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018; 73 (4): 765–798. https://doi.org/10.1111/all.13317.Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018; 73 (4): 765–798. https://doi.org/10.1111/all.13317.Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011; 127 (1): 1–55. https://doi.org/10.1016/j.jaci.2010.09.034.Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011; 127 (1): 1–55. https://doi.org/10.1016/j.jaci.2010.09.034.Pitsios C, Demoly P, Bilò MB, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015; 70 (8): 897–909. https://doi.org/10.1111/all.12638.Pitsios C, Demoly P, Bilò MB, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015; 70 (8): 897–909. https://doi.org/10.1111/all.12638.Pitsios C, Tsoumani M., Bilò MB, et al. Contraindications to immunotherapy: a global approach. Clin Transl Allergy. 2019; 9: 45. https://doi.org/10.1186/s13601-019-0285-4.Pitsios C, Tsoumani M., Bilò MB, et al. Contraindications to immunotherapy: a global approach. Clin Transl Allergy. 2019; 9: 45. https://doi.org/10.1186/s13601-019-0285-4.Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019; 74 (11): 2087–2102. https://doi.org/10.1111/all.13805.Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019; 74 (11): 2087–2102. https://doi.org/10.1111/all.13805.Agache I, Lau S, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019; 74 (5): 855–873. https://doi.org/10.1111/all.13749.Agache I, Lau S, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019; 74 (5): 855–873. https://doi.org/10.1111/all.13749.Pfaar O, Ankermann T, Augustin M, et al. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Al lergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD). Allergol Select. 2022; 6: 67–232. https://doi.org/10.5414/ALX02331E.Pfaar O, Ankermann T, Augustin M, et al. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Al lergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD). Allergol Select. 2022; 6: 67–232. https://doi.org/10.5414/ALX02331E.Ferrando M, Racca F, Madeira LNG, et al. A critical appraisal on AIT in childhood asthma. Clin Mol Allergy. 2018; 16: 6. https:// doi.org/10.1186/s12948-018-0085-8.Ferrando M, Racca F, Madeira LNG, et al. A critical appraisal on AIT in childhood asthma. Clin Mol Allergy. 2018; 16: 6. https:// doi.org/10.1186/s12948-018-0085-8.Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010; 125 (3): 569–574, 574.e1–574.e7. https://doi.org/10.1016/j.jaci.2009.10.060.Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010; 125 (3): 569–574, 574.e1–574.e7. https://doi.org/10.1016/j.jaci.2009.10.060.Iemoli E, Borgonovo L, Fusi A, et al. Sublingual allergen immunotherapy in HIV-positive patients. Allergy. 2016; 71: 412– 415. https://doi.org/10.1111/all.12713.Iemoli E, Borgonovo L, Fusi A, et al. Sublingual allergen immunotherapy in HIV-positive patients. Allergy. 2016; 71: 412– 415. https://doi.org/10.1111/all.12713.Linneberg A, Madsen F, Skaaby T. Allergen-specific immunotherapy and risk of autoimmune disease. Curr Opin Allergy Clin Immunol. 2012; 12 (6): 635–639. https://doi.org/10.1097/ACI.0b013e3283588c8d.Linneberg A, Madsen F, Skaaby T. Allergen-specific immunotherapy and risk of autoimmune disease. Curr Opin Allergy Clin Immunol. 2012; 12 (6): 635–639. https://doi.org/10.1097/ACI.0b013e3283588c8d.Wollenberg A, Barbarot S, Bieber T, et al. European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018; 32 (6): 850–878. https://doi.org/10.1111/jdv.14888.Wollenberg A, Barbarot S, Bieber T, et al. European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018; 32 (6): 850–878. https://doi.org/10.1111/jdv.14888.Egan M, Atkins D. What Is the Relationship Between Eosinophilic Esophagitis (EoE) and Aeroallergens? Implications for Allergen Immunotherapy. Curr Allergy Asthma Rep. 2018; 18 (8): 43. https://doi.org/10.1007/s11882-018-0798-2.Egan M, Atkins D. What Is the Relationship Between Eosinophilic Esophagitis (EoE) and Aeroallergens? Implications for Allergen Immunotherapy. Curr Allergy Asthma Rep. 2018; 18 (8): 43. https://doi.org/10.1007/s11882-018-0798-2.Wang C, Bao Y, Chen J, et al. Chinese Society of Allergy (CSA) and Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G). Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update. Allergy Asthma Immunol Res. 2022; 14 (6): 604–652. https://doi.org/10.4168/aair.2022.14.6.604.Wang C, Bao Y, Chen J, et al. Chinese Society of Allergy (CSA) and Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G). Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update. Allergy Asthma Immunol Res. 2022; 14 (6): 604–652. https://doi.org/10.4168/aair.2022.14.6.604.Gao Y, Lin X, Ma J, et al. Enhanced Efficacy of Dust Mite Sublingual Immunotherapy in Low-Response Allergic Rhinitis Patients after Dose Increment at 6 Months: A Prospective Study. International archives of allergy and immunology. 2020; 181 (4): 311–319. https://doi.org/10.1159/000505746.Gao Y, Lin X, Ma J, et al. Enhanced Efficacy of Dust Mite Sublingual Immunotherapy in Low-Response Allergic Rhinitis Patients after Dose Increment at 6 Months: A Prospective Study. International archives of allergy and immunology. 2020; 181 (4): 311–319. https://doi.org/10.1159/000505746.Chen S, Zheng Y, Chen B, et al. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens. Int Arch Allergy Immunol. 2019; 178 (2): 201–210. https://doi.org/10.1159/000494389.Chen S, Zheng Y, Chen B, et al. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens. Int Arch Allergy Immunol. 2019; 178 (2): 201–210. https://doi.org/10.1159/000494389.Fortescue R, Kew KM, Leung MST. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2020; 9: CD011293. https://doi.org/10.1002/14651858.CD011293.pub3.Fortescue R, Kew KM, Leung MST. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2020; 9: CD011293. https://doi.org/10.1002/14651858.CD011293.pub3.Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database of Systematic Reviews. 2010; (12). https://doi.org/10.1002/14651858.CD002893.pub2.Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database of Systematic Reviews. 2010; (12). https://doi.org/10.1002/14651858.CD002893.pub2.Клинические рекомендации. Атопический дерматит. 2021. https://cr.minzdrav.gov.ru/recomend/265_2. Дата обращения 18.06.2023.Klinicheskie rekomendacii. Atopicheskij dermatit. 2021. https://cr.minzdrav.gov.ru/recomend/265_2. Vremya dostupa 18.06.2023 (In Russ.)Lee J, Lee H, Noh S, et al. Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis. Yonsei Med J. 2016; 57 (2): 393–398. https://doi.org/10.3349/ymj.2016.57.2.393.Lee J, Lee H, Noh S, et al. Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis. Yonsei Med J. 2016; 57 (2): 393–398. https://doi.org/10.3349/ymj.2016.57.2.393.Liu L, Chen J, Xu J, et al. Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study. Artif Cells Nanomed Biotechnol. 2019; 47 (1): 3540–3547. https://doi.org/10.1080/21691401.2019.1640709.Liu L, Chen J, Xu J, et al. Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study. Artif Cells Nanomed Biotechnol. 2019; 47 (1): 3540–3547. https://doi.org/10.1080/21691401.2019.1640709.Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. Journal of Allergy and Clinical Immunology. 2010; 126 (5): 969–975. https://doi.org/10.1016/j.jaci.2010.08.030.Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. Journal of Allergy and Clinical Immunology. 2010; 126 (5): 969–975. https://doi.org/10.1016/j.jaci.2010.08.030.Trebuchon F, Lhéritier-Barrand M, David M, Demoly P. Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens. Clin Transl Allergy. 2014; 4: 15. https://doi.org/10.1186/2045-7022-4-15.Trebuchon F, Lhéritier-Barrand M, David M, Demoly P. Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens. Clin Transl Allergy. 2014; 4: 15. https://doi.org/10.1186/2045-7022-4-15.Demoly P, Meziane L, LeGall M, et al. Safety and tolerability of house dust mite tablets in sublingual immunotherapy. J Allergy Clin Immunol. 2008; 121: S128.Demoly P, Meziane L, LeGall M, et al. Safety and tolerability of house dust mite tablets in sublingual immunotherapy. J Allergy Clin Immunol. 2008; 121: S128.Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2014; 134: 568–575.Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2014; 134: 568–575.Mösges R, Ritter B, Kayoko G, Passali D, Allekotte S. Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais tablets. Acta Dermatovenerol Alp Pannonica Adriat. 2010 Oct; 19 (3): 3–10.Mösges R, Ritter B, Kayoko G, Passali D, Allekotte S. Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais tablets. Acta Dermatovenerol Alp Pannonica Adriat. 2010 Oct; 19 (3): 3–10.Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma.CochraneAirwaysGroup,ed.Cochrane Database of Systematic Reviews. Published on line August 4, 2010. https://doi.org/10.1002/14651858.CD001186.pub2.Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma.CochraneAirwaysGroup,ed.Cochrane Database of Systematic Reviews. Published on line August 4, 2010. https://doi.org/10.1002/14651858.CD001186.pub2.Гайдук ИМ, Макарова ИВ, Трусова ОВ, Брейкин ДВ, Сухорукова ВГ, Аракелян РН, Коростовцев ДС. Аллерген-специфическая иммунотерапия пыльцевыми аллергоидами у детей. Российский аллергологический журнал. 2009; 1: 45–50.Gajduk IM, Makarova IV, Trusova OV, Brejkin DV, Suhorukova VG, Arakelyan RN, Korostovtsev DS. Allergen-specificheskaya immunoterapiya pyl’cevymi allergoidami u detej. Rossijskij allergologicheskij zhurnal. 2009; 1: 45–50. (In Russ.)Worm M, Rak S, DeBlay F et al. Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: result of a double-blind, placebo-controlledstudy.Clinical and Translational Allergy. 2014; 4: 1–11.Worm M, Rak S, DeBlay F et al. Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: result of a double-blind, placebo-controlledstudy.Clinical and Translational Allergy. 2014; 4: 1–11.Wahn U, Tabar A, Kuna P et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology. 2009; 123 (1): 160–166.e3. https://doi.org/10.1016/j.jaci.2008.10.009.Wahn U, Tabar A, Kuna P et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology. 2009; 123 (1): 160–166.e3. https://doi.org/10.1016/j.jaci.2008.10.009.Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grasssublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass-pollen allergy. J Allergy Clin Immunol. 2018; 141 (2): 529–538.e13. https://doi.org/10.1016/j.jaci.2017.06.014.Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grasssublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass-pollen allergy. J Allergy Clin Immunol. 2018; 141 (2): 529–538.e13. https://doi.org/10.1016/j.jaci.2017.06.014.Nolte H, Bernstein DI, Nelson HS, et al. Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial. J Allergy Clin Immunol Pract. 2020; 8 (7): 2322–2331.e5. https://doi.org/10.1016/j.jaip.2020.03.041.Nolte H, Bernstein DI, Nelson HS, et al. Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial. J Allergy Clin Immunol Pract. 2020; 8 (7): 2322–2331.e5. https://doi.org/10.1016/j.jaip.2020.03.041.Maloney J, Berman G, Gagnon R, et al. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous TreatmentIs Well Tolerated. J Allergy Clin Immunol Pract. 2016; 4 (2): 301-309.e2. https://doi.org/10.1016/j.jaip.2015.11.004.Maloney J, Berman G, Gagnon R, et al. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous TreatmentIs Well Tolerated. J Allergy Clin Immunol Pract. 2016; 4 (2): 301-309.e2. https://doi.org/10.1016/j.jaip.2015.11.004.Bousquet J, Hejjaoui A, Dhivert H, etal.Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol. 1989; 83 (4): 797–802. https://doi.org/10.1016/0091-6749(89)90017-1.Bousquet J, Hejjaoui A, Dhivert H, etal.Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol. 1989; 83 (4): 797–802. https://doi.org/10.1016/0091-6749(89)90017-1.Смолкин ЮС, Максимова АВ. Особенности профилактической вакцинации детей с аллергическими заболеваниями. Учеб.- метод. пособие. Москва. Изд-во Академии постдипломного образования ФГБУ ФНКЦ ФМБА России, 2020. 52 с. ISBN 978-5-7151-0559-2.Smolkin YuS, Maksimova AV. Osobennosti profilakticheskoj vakcinacii detej s allergicheskimi zabolevaniyami. Ucheb.-metod. posobie. Moskva. Izd-vo Akademii postdiplomnogo obrazovaniya FGBU FNKC FMBA Rossii, 2020. 52 s. ISBN 978-5-7151-0559-2. (In Russ.)Chen K-W, Zieglmayer P, Zieglmayer R et al. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy. Journal of Allergy and Clinical Immunology. 2019; 143 (3): 1248–1252.Chen K-W, Zieglmayer P, Zieglmayer R et al. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy. Journal of Allergy and Clinical Immunology. 2019; 143 (3): 1248–1252.Sastre J, Rodrıguez F, Campo P, et al. Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens. Allergy. 2015; 70 (5): 598–600.Sastre J, Rodrıguez F, Campo P, et al. Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens. Allergy. 2015; 70 (5): 598–600.Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017; 72 (8): 1156–1173. https://doi.org/10.1111/all.13138.Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017; 72 (8): 1156–1173. https://doi.org/10.1111/all.13138.Барычева ЛЮ, Душина ЛВ, Медведенко ЮН. Изменение реактивности базофилов и синтеза специфических иммуноглобулинов Е под влиянием аллерген-иммунотерапии. Аллергология и иммунология в педиатрии. 2020; 1 (64): 15–23. https://doi.org/10.24412/2500-1175-2021-1-15-23.Barycheva LYU, Dushina LV, Medvedenko YUN. Izmenenie reaktivnosti bazofilov i sinteza specificheskih immunoglobulinov E pod vliyaniem allergen-immunoterapii. Allergologiya i immunologiya v pediatrii. 2020; 1 (64): 15–23. https://doi.org/10.24412/2500-1175-2021-1-15-23. (In Russ.)Частная аллергология. Под ред. Адо А. Д. М.: «Медицина», 1976. 512 с.Chastnaya allergologiya. Pod red. Ado A. D. M.: «Medicina », 1976. 512 s. (In Russ.)Pfaar O, Demoly P, Gerth van Wijk R,et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014; 69 (7): 854–867.Pfaar O, Demoly P, Gerth van Wijk R,et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014; 69 (7): 854–867.Тактика диагностики и лечения аллергических заболеваний и иммунодефицитов: практическое руководство / под ред. Р. М.Хаитова. — М.: ГЭОТАР-Медиа, 2019. — 152 с. DOI: 10.33029/9704-5200-4-TER-2019-1-152.Taktika diagnostiki i lecheniya allergicheskih zabolevanij i immunodeficitov: prakticheskoe rukovodstvo / pod red. R. M. Haitova. — M.: GEOTAR-Media, 2019. — 152 s. https://doi.org/10.33029/9704-5200-4-TER-2019-1-152. (In Russ.)Bae JM, Choi YY, Park CO, et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: asystematic review and meta- analysis of randomized controlled trials. J Allergy Clin Immunol. 2013; 132: 110–117. https://doi.org/10.1016/j.jaci.2013.02.044.Bae JM, Choi YY, Park CO, et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: asystematic review and meta- analysis of randomized controlled trials. J Allergy Clin Immunol. 2013; 132: 110–117. https://doi.org/10.1016/j.jaci.2013.02.044.Traidl S, Werfel T. Allergen immunotherapy for atopic dermatitis. Hautarzt. 2021; 72 (12): 1103–1112. https://doi.org/10.1007/s00105-021-04909-y.Traidl S, Werfel T. Allergen immunotherapy for atopic dermatitis. Hautarzt. 2021; 72 (12): 1103–1112. https://doi.org/10.1007/s00105-021-04909-y.Valera CP, Coelho EB, Galvao CES, et al. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2022; 10 (2): 539–549.e7. https://doi.org/10.1016/j.jaip.2021.10.060.Valera CP, Coelho EB, Galvao CES, et al. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2022; 10 (2): 539–549.e7. https://doi.org/10.1016/j.jaip.2021.10.060.Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. 2005; 116 (5): 1073–1079. https://doi.org/10.1016/j.jaci.2005.08.027.Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. 2005; 116 (5): 1073–1079. https://doi.org/10.1016/j.jaci.2005.08.027.Romantsik O, Tosca MA, Zappettini S, Calevo MG. Oral and sublingual immunotherapy for egg allergy (Review). Cochrane Database Syst Rev. 2018; (4): CD010638.Romantsik O, Tosca MA, Zappettini S, Calevo MG. Oral and sublingual immunotherapy for egg allergy (Review). Cochrane Database Syst Rev. 2018; (4): CD010638.Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI guidelines on allergen immunotherapy: IgE mediated food allergy. Allergy. 2018; 73: 799–815.Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI guidelines on allergen immunotherapy: IgE mediated food allergy. Allergy. 2018; 73: 799–815.AAAAI current status of oral immunotherapy (ICU) for the treatment of food allergies. [accessed April 1, 2020; available on the Internet: https://www.aaaai.org/conditions-and-treatments/library/allergy-library/oit.AAAAI current status of oral immunotherapy (ICU) for the treatment of food allergies. [accessed April 1, 2020; available on the Internet: https://www.aaaai.org/conditions-and-treatments/library/allergy-library/oit.Virchow JC, Backer V, Kuna P, et al. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma. JAMA. 2016; 315 (16): 1715. https://doi.org/10.1001/jama.2016.3964.Virchow JC, Backer V, Kuna P, et al. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma. JAMA. 2016; 315 (16): 1715. https://doi.org/10.1001/jama.2016.3964.Wang L, Wang C, Lou H, et al. Antihistamine premedication improves safety and efficacy of allergen immunotherapy. Ann Allergy Asthma Immunol. 2021; 127 (3): 363–371.Wang L, Wang C, Lou H, et al. Antihistamine premedication improves safety and efficacy of allergen immunotherapy. Ann Allergy Asthma Immunol. 2021; 127 (3): 363–371.Lee TH, Chan JKC, Lau PC, et al. Peanut allergy and oral immunotherapy. Hong Kong Med J. 2019; 25 (3): 228–234. https://doi.org/10.12809/hkmj187743.Lee TH, Chan JKC, Lau PC, et al. Peanut allergy and oral immunotherapy. Hong Kong Med J. 2019; 25 (3): 228–234. https://doi.org/10.12809/hkmj187743.

The authors declare that there are no conflicts of interest present.